Kerecis Launches SurgiClose Silicone for Surgical and Trauma Wounds

Kerecis, a company pioneering sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, has launched its SurgiClose silicone product. The product combines a fish-skin graft and silicone backing to treat surgical and trauma wounds.

The SurgiClose product family is intact fish-skin meant to manage trauma wounds and surgical wounds in the operating room. The new product comes in two variations.

SurgiClose silicone adhesive has borders that overlap the fish-skin underneath. SurgiClose silicone standard has non-overlapping borders.

“Applying Kerecis fish-skin to a surgical or trauma wound is a multi-step process that often requires supporting products such as sutures, staples, surgical tapes, contact layers, and wound-dressings,” said Fertram Sigurjonsson, Kerecis’ founder and CEO. The new SurgiClose Silicone product combines the fish-skin with a silicone-contact layer and thus eliminates the need for one of the supporting products. This makes the workflow in the surgical theater simpler and more cost effective.”

Last month, Kerecis unveiled its first European Center of Excellence for its fish-skin tech. The company’s Centers of Excellence are meant to be hubs for peer-to-peer mentoring, advanced training, and collaborative research. The new facility extends the company’s Center of Excellence program outside the U.S. for the first time.

Kerecis was acquired by Coloplast in a $1.3 billion, upfront cash deal in 2023.